Management of Hepato-toxicity During treatment with MDR/RR-TB Regimen

  • Identify the risk factors associated with hepatotoxicity during treatment with shorter or longer oral multidrug-resistant tuberculosis (MDR-TB) regimens.
  • Learn to recognize the signs and symptoms of hepatotoxicity in patients undergoing MDR-TB treatment.
  • Develop proficiency in managing hepatotoxicity reactions, including dose adjustments, temporary cessation of offending medications, or alternative regimen selection.
Subscribe to